NCM
Nantahala Capital Management Portfolio holdings
AUM
$1.68B
1-Year Est. Return
115.06%
This Fund
S&P 500
1 Year Est. Return
+115.06%
AUM
$1.68B
AUM Growth
+$58.5M
(+3.6%)
Holding
160
Top Buys
| 1 | +$49.8M | |
| 2 | +$28.8M | |
| 3 | +$27.8M | |
| 4 |
Soleno Therapeutics
SLNO
|
+$24.7M |
| 5 |
Peloton Interactive
PTON
|
+$15.7M |
Top Sells
| 1 | +$59.5M | |
| 2 | +$44.1M | |
| 3 | +$35.3M | |
| 4 |
Amneal Pharmaceuticals
AMRX
|
+$20.3M |
| 5 |
IMAX
IMAX
|
+$18.1M |
Sector Composition
| 1 | Healthcare | 62.18% |
| 2 | Consumer Discretionary | 15.78% |
| 3 | Financials | 6.34% |
| 4 | Communication Services | 5.5% |
| 5 | Industrials | 2.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Codexis
CDXS
$112M
| $6.5M | 0.39% |
3,990,169
-40,450
|
|
||
77
DarioHealth
DRIO
$61.8M
| $6.41M | 0.38% |
563,232
-1
|
|
||
|
CNTA
78
Centessa Pharmaceuticals
CNTA
$4.08B
| $6.37M | 0.38% |
254,803
-150,000
|
|
||
79
TELA Bio
TELA
$37.5M
| $6.03M | 0.36% |
5,111,588
|
|
||
80
InspireMD
NSPR
$69.5M
| $6.01M | 0.36% |
3,376,484
|
|
||
81
Unicycive Therapeutics
UNCY
$149M
| $5.42M | 0.32% |
939,202
|
|
||
82
Assertio
ASRT
$74.6M
| $5.33M | 0.32% |
587,335
-3
|
|
||
83
Surrozen
SRZN
$238M
| $5.19M | 0.31% |
229,527
|
|
||
84
Korro Bio
KRRO
$108M
| $4.81M | 0.29% |
+600,000
|
|
||
85
Nektar Therapeutics
NKTR
$2.02B
| $4.78M | 0.28% |
112,946
-305,576
|
|
||
86
Neuropace
NPCE
$474M
| $4.56M | 0.27% |
295,089
|
|
||
87
CG Oncology
CGON
$5.3B
| $4.54M | 0.27% |
109,449
|
|
||
88
Alta Equipment Group
ALTG
$210M
| $4.3M | 0.26% |
934,774
|
|
||
89
Destination XL Group
DXLG
$28.3M
| $4.14M | 0.25% |
4,505,000
|
|
||
90
Mineralys Therapeutics
MLYS
$2.25B
| $4.11M | 0.25% |
113,285
-45,428
|
|
||
|
GRCE
91
Grace Therapeutics
GRCE
$61.1M
| $4.08M | 0.24% |
1,178,203
|
|
||
92
Talphera
TLPH
$41.3M
| $3.98M | 0.24% |
3,492,519
|
|
||
93
The ONE Group
STKS
$60M
| $3.71M | 0.22% |
2,121,084
|
|
||
94
DHI Group
DHX
$110M
| $3.68M | 0.22% |
2,374,027
|
|
||
95
Verastem
VSTM
$481M
| $3.57M | 0.21% |
462,140
-830,763
|
|
||
96
Arvinas
ARVN
$885M
| $3.56M | 0.21% |
+300,000
|
|
||
97
OrthoPediatrics
KIDS
$447M
| $3.54M | 0.21% |
199,449
+150,000
|
|
||
98
Gaia
GAIA
$76.6M
| $3.32M | 0.2% |
914,618
|
|
||
99
Achieve Life Sciences
ACHV
$228M
| $3.22M | 0.19% |
648,885
|
|
||
100
Akebia Therapeutics
AKBA
$370M
| $3.22M | 0.19% |
2,000,000
|
|